FGFR and VEGFR inhibitors are provided, and compounds represented by formula (1) or formula (II) as FGFR and VEGFR inhibitors, pharmaceutically acceptable salts or tautomers thereof are specifically disclosed.
提供了
表皮生长因子受体(FGFR)和血管内皮生长因子受体(V
EGFR)
抑制剂,并特别公开了作为
表皮生长因子受体(FGFR)和血管内皮生长因子受体(V
EGFR)
抑制剂的式(1)或式(II)所代表的化合物、其药学上可接受的盐或同系物。